RxDoctor Payments Data

Mark Hollman, MD

Orthopaedic Surgery · Deland, FLNPI 1457315772

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Exactech, Inc. accounts for 86.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $38,824 and has fallen 99.7% since, to $99 in 2025.

$74,820in general payments, 2019–2025

Across 88 payments — averaging $850.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exactech, Inc.$65K
  • Depuy Synthes Products, Inc.$6K
  • Pacira Therapeutics, Inc.$3K
  • Stryker$242
  • Radius Health, Inc.$182
  • Kerecis Limited$140
  • plus $691 from 16 others
$800,655in research payments, 2019–2025

Across 224 payments — averaging $3574.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$390K
  • Exactech, Inc.$384K
  • Advita Ortho, LLC$13K
  • Endo Pharmaceuticals Inc.$5K
  • Pacira Therapeutics, Inc.$4K
  • Janssen Research & Development, LLC$3K
  • plus $2K from 1 others

What the payments were for

  • Consulting fees$33,85245%
  • Speaking & faculty fees$32,37543%
  • Travel & lodging$6,1788%
  • Food & beverage$2,4153%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,820 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$282,467
Medicare patients
595
Services billed
2,863

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin28$684
Ondansetron OdtOndansetron22$352
Amoxicillin56$296
Oxycodone Hcl50$275
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$164
Alendronate Sodium25$124
Diclofenac Sodium12$122
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$120
Tramadol Hcl19$46
Meloxicam13$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Deland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →